Effects of Organic Acids on Drug Release From Ternary Polypeptide Nanoparticles Entrapping Carfilzomib
- 20 September 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 111 (4), 1172-1177
- https://doi.org/10.1016/j.xphs.2021.09.022
Abstract
No abstract availableFunding Information
- NIA (R01 AG073122)
- National Institutes of Health
This publication has 51 references indexed in Scilit:
- Characterization of magnetic nanoparticle by dynamic light scatteringNanoscale Research Letters, 2013
- U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple MyelomaClinical Cancer Research, 2013
- A phase I/II study of carfilzomib 2–10-min infusion in patients with advanced solid tumorsCancer Chemotherapy and Pharmacology, 2013
- A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myelomaBlood, 2012
- Nanoparticle-based targeted drug deliveryExperimental and Molecular Pathology, 2009
- Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacyAdvanced Drug Delivery Reviews, 2009
- Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cellsCancer Letters, 2006
- PEG-modified gold nanorods with a stealth character for in vivo applicationsJournal of Controlled Release, 2006
- Multi-functional polymeric nanoparticles for tumour-targeted drug deliveryExpert Opinion on Drug Delivery, 2006
- The safety of pharmaceutical excipientsIl Farmaco, 2003